A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors.
Clinical trial NCT03545971 · COMPLETED
Trial details
- NCT number
- NCT03545971
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2021-09-10
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.